Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2025-12-24 @ 9:48 PM
NCT ID:
NCT02245932
Eligibility Criteria:
Inclusion Criteria:
* COPD patients
* Current or ex-smoker
* Age \>18 years
Exclusion Criteria:
* COPD patients planned for pulmonary rehabilitation or who recently participated in a rehabilitation program in the previous 6 months
* Investigator's uncertainty about willingness or ability of the patient to comply with the protocol requirements
* Participation in any other study involving investigational exercise training, nutritional or pharmacological intervention
* Oral glucocorticoid use
* Recent exacerbation (\<4 weeks) that required oral steroids and/or hospital admission
* Subject is pregnant, planning to be pregnant during the study period, lactating, or women who consider themselves to be of childbearing potential and who are engaged in an active sex life and are unwilling to commit to the use of an approved form of contraception throughout the study period. The method of contraception must be recorded in the source documentation;
* Diabetes mellitus (all types), active cardiovascular disease or a cardiovascular event (such as myocardial infarction, cerebrovascular haemorrhage/infarction) in the previous 6 months, recent major surgery, thyroid dysfunction, hepatic or renal disorders, current malignancy (except for dermal malignancies) or central or obstructive sleep apnea;
* Current alcohol consumption \> 20 grams alcohol/day;
* Intake of resveratrol containing dietary supplements.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02245932
Study Brief:
Protocol Section:
NCT02245932